Showing results for "Drug Discovery" in All Categories

The search to find medicines is as old as disease, which is to say as old as the human race. Through serendipity - by chewing, brewing, and snorting - some Neolithic souls discovered opium, alcohol, snakeroot, juniper, frankincense, and other helpful substances. Ötzi the Iceman, the 5,000-year-old hunter frozen in the Italian Alps, was found to have whipworms in his intestines and Bronze Age medicine, a worm-killing birch fungus, knotted to his leggings.

Late-breaking advances in AI-enabled drug discovery, including news, research progress, market trends, and interviews

During her two decades at The New England Journal of Medicine, Dr. Marcia Angell had a front-row seat on the appalling spectacle of the pharmaceutical industry. She watched drug companies stray from their original mission of discovering and manufacturing useful drugs and instead become vast...

A conversation with Dr. Anand Krishnamurthy, Senior Manager, Industry Process Consultant, BIOVIA, Dassault Systèmes on the importance of Artificial Intelligence in the field of drug discovery.

Podcast refers to topics related to research and development in drug discovery and computational drug design. Interviews with experts in this field of Drug Discovery. @giribio

From one of the world's foremost experts on the subject, a powerful argument that the greatest damage from drugs flows from their being illegal, and a hopeful reckoning with the possibility of their use as part of a responsible and happy life Dr. Carl L. Hart, Ziff Professor at Columbia...

DDN Dialogues is a new podcast from Drug Discovery News. Join us as we explore the stories behind the latest advances in drug discovery research.

Drug Discovery News Talks Science is a podcast where we discuss the latest news in preclinical and translational research. Behind every medical and scientific advancement lies a harrowing story of mystery and discovery. Come with us as we share these stories and connect you to the scientific minds behind them.

In this podcast miniseries, learn about the scientific, technological and logistical aspects of using CRISPR to generate animal models in drug development. Hosted by The CRISPR Journal’s Executive Editor Kevin Davies, the series features experts from Taconic discussing key issues in using CRISPR to produce precision gene edits, including considerations around licensing and intellectual property. See acast.com/privacy for privacy and opt-out information.